DE69320875T2 - Fumarsäuresalze von Chinolinderivaten zur Aufhebung von vielfacher Drogenresistenz in der Krebsbehandlung - Google Patents
Fumarsäuresalze von Chinolinderivaten zur Aufhebung von vielfacher Drogenresistenz in der KrebsbehandlungInfo
- Publication number
- DE69320875T2 DE69320875T2 DE69320875T DE69320875T DE69320875T2 DE 69320875 T2 DE69320875 T2 DE 69320875T2 DE 69320875 T DE69320875 T DE 69320875T DE 69320875 T DE69320875 T DE 69320875T DE 69320875 T2 DE69320875 T2 DE 69320875T2
- Authority
- DE
- Germany
- Prior art keywords
- elimination
- fumaric acid
- acid salts
- drug resistance
- cancer treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP04159318A JP3076672B2 (ja) | 1992-06-18 | 1992-06-18 | キノリン誘導体のフマル酸塩 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69320875D1 DE69320875D1 (de) | 1998-10-15 |
DE69320875T2 true DE69320875T2 (de) | 1999-04-08 |
Family
ID=15691180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69320875T Expired - Fee Related DE69320875T2 (de) | 1992-06-18 | 1993-06-17 | Fumarsäuresalze von Chinolinderivaten zur Aufhebung von vielfacher Drogenresistenz in der Krebsbehandlung |
Country Status (5)
Country | Link |
---|---|
US (1) | US5434155A (de) |
EP (1) | EP0575890B1 (de) |
JP (1) | JP3076672B2 (de) |
CN (1) | CN1037266C (de) |
DE (1) | DE69320875T2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643909A (en) * | 1993-04-19 | 1997-07-01 | Syntex (U.S.A.) Inc. | 10,11-Methanodibenzosuberane derivatives |
US6025359A (en) * | 1996-06-17 | 2000-02-15 | Eli Lilly And Company | Drug resistance and multidrug resistance modulators |
KR20000057157A (ko) * | 1996-11-22 | 2000-09-15 | 피터 지. 스트링거 | 약물 내성 및 복합 약물 내성 조절제 |
JP2000290181A (ja) * | 1999-04-01 | 2000-10-17 | Mitsui Chemicals Inc | 脳疾患治療薬脳内移行増強剤 |
KR20030015655A (ko) * | 2001-08-17 | 2003-02-25 | 한미약품공업 주식회사 | 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물 |
US7462718B2 (en) | 2003-05-06 | 2008-12-09 | Schering Ag | Process for the production of high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and high-purity rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]piperazin-1-yl}-2,2-diphenylethan-1-one fumarate |
DE10321255B4 (de) * | 2003-05-06 | 2006-09-28 | Schering Ag | Verfahren zur Herstellung von reinstem rac-1{4-[2- Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarat und reinstes rac-1{4-[2-Hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2 |
MX2013007295A (es) | 2010-12-23 | 2013-08-26 | Merck Sharp & Dohme | Quinoxalinas y aza-quinoxalinas como moduladores del receptor de crth2. |
WO2012087872A1 (en) * | 2010-12-23 | 2012-06-28 | Merck Sharp & Dohme Corp. | Quinolines and aza-quinolines as crth2 receptor modulators |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3600390A1 (de) * | 1986-01-09 | 1987-07-16 | Hoechst Ag | Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel |
US4965271A (en) * | 1986-12-31 | 1990-10-23 | Hoechst Roussel Pharmaceuticals, Inc. | Method of inhibiting the activity of leukocyte derived cytokines |
US5204348A (en) * | 1988-10-06 | 1993-04-20 | Mitsui Toatsu Chemicals Inc. | Heterocyclic compounds and anticancer-drug potentiaters conaining them as effective components |
CA1340821C (en) * | 1988-10-06 | 1999-11-16 | Nobuyuki Fukazawa | Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components |
US5039666A (en) * | 1990-10-30 | 1991-08-13 | Hoechst-Roussel Pharmaceuticals Inc. | Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside |
-
1992
- 1992-06-18 JP JP04159318A patent/JP3076672B2/ja not_active Expired - Fee Related
-
1993
- 1993-06-15 US US08/076,589 patent/US5434155A/en not_active Expired - Lifetime
- 1993-06-17 EP EP93109685A patent/EP0575890B1/de not_active Expired - Lifetime
- 1993-06-17 DE DE69320875T patent/DE69320875T2/de not_active Expired - Fee Related
- 1993-06-18 CN CN93107729A patent/CN1037266C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3076672B2 (ja) | 2000-08-14 |
EP0575890B1 (de) | 1998-09-09 |
EP0575890A1 (de) | 1993-12-29 |
CN1083476A (zh) | 1994-03-09 |
US5434155A (en) | 1995-07-18 |
CN1037266C (zh) | 1998-02-04 |
DE69320875D1 (de) | 1998-10-15 |
JPH061768A (ja) | 1994-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300014I1 (nl) | Chinolinederivaten en bereidingsprocessen hiervoor. | |
DE3683318D1 (de) | Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege. | |
DE69030825D1 (de) | Katheter zur gleichmässigen Verteilung von therapeutischen Flüssigkeiten | |
DK0509704T3 (da) | Biomedicinsk elektrode med centralt placeret fligkonstruktion | |
FI874671A0 (fi) | Anordning foer foerhindrande av laeckage i tryckledningar. | |
DE69224529D1 (de) | Elektroden-anordnung zur nerven-reizung | |
NO851501L (no) | Fremgangsmaate for fremstilling av antibakterielle naftyriden-, kinolin- og benzoksazin-karboksylsyrer | |
DE3789642D1 (de) | Apparat zur iontophoretischen behandlung mit medikamenten. | |
DK439688A (da) | Quinoloner | |
DE69513672D1 (de) | Verbesserte vorrichtung zur iontophoretischen verabreichung von medikamenten | |
DE69320875D1 (de) | Fumarsäuresalze von Chinolinderivaten zur Aufhebung von vielfacher Drogenresistenz in der Krebsbehandlung | |
BR8805195A (pt) | Nucleo de transformador aperfeicoado | |
NO860870L (no) | Kinolonkarboksylsyrederivater. | |
ATE91625T1 (de) | Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren. | |
NO930520D0 (no) | Bifenyl-substituerte kinolinderivater | |
KR930702990A (ko) | 섬유성 질병 치료제로서의 프로스타사이클린- 및 카르바사이클린 유도체 | |
ZA914323B (en) | Benzoic acid derivatives for treating leukotriene-related diseases | |
GR861529B (en) | 1,4-dihydropyridine derivatives used for the treatment of cardiovascular diseases | |
DE3664770D1 (de) | Cardiotonic quinazoline derivatives | |
IL98412A0 (en) | Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases | |
DE3668116D1 (de) | Zusammensetzung zur behandlung von infektionen. | |
MD349B1 (ro) | Stimulator ionic bipolar | |
ATE336282T1 (de) | Katheter zur behandlung von prostaterkrankungen | |
DE3885283D1 (de) | Verfahren zur unterschiedlichen randwärmebehandlung zur herstellung von werkstücken mit dualen eigenschaften. | |
FI971012A (fi) | 1,4-dihydro-4-okso-3-kinoliinikarboksyylihappojohdannaiset ja niiden käyttö |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SCHERING AG, 13353 BERLIN, DE |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: BAYER SCHERING PHARMA AG, 13353 BERLIN, DE |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: BAYER SCHERING PHARMA AKIENGESELLSCHAFT, 13353, DE |
|
8339 | Ceased/non-payment of the annual fee |